Mirum Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2018
Revenue	336.89	186.37	77.06	19.14	-	Upgrade
Revenue Growth (YoY)	80.76%	141.85%	302.67%	-	-	Upgrade
Cost of Revenue	81.64	47.04	12.37	1.9	-	Upgrade
Gross Profit	255.25	139.34	64.69	17.24	-	Upgrade
Selling, General & Admin	202.22	145.88	89.07	59.22	22.69	Upgrade
Research & Development	140.63	102.61	106.84	131.43	81.61	Upgrade
Operating Expenses	342.85	248.49	195.91	190.65	104.3	Upgrade
Operating Income	-87.61	-109.15	-131.22	-173.41	-104.3	Upgrade
Interest Expense	-14.31	-15.11	-15.98	-17.59	-0.34	Upgrade
Interest & Investment Income	13.79	13.74	3.86	0.37	1.56	Upgrade
Currency Exchange Gain (Loss)	1.2	1.8	-	-	-	Upgrade
Other Non Operating Income (Expenses)	0.01	-4.62	1.27	106.69	-0.19	Upgrade
EBT Excluding Unusual Items	-86.91	-113.35	-142.07	-83.95	-103.26	Upgrade
Other Unusual Items	-	-49.08	-	-	-	Upgrade
Pretax Income	-86.91	-162.42	-142.07	-83.95	-103.26	Upgrade
Income Tax Expense	1.03	0.99	-6.41	0.04	0.01	Upgrade
Net Income	-87.94	-163.42	-135.67	-83.99	-103.27	Upgrade
Net Income to Common	-87.94	-163.42	-135.67	-83.99	-103.27	Upgrade
Shares Outstanding (Basic)	48	41	34	30	25	Upgrade
Shares Outstanding (Diluted)	48	41	34	30	25	Upgrade
Shares Change (YoY)	16.23%	20.31%	12.07%	20.08%	119.84%	Upgrade
EPS (Basic)	-1.85	-4.00	-4.01	-2.77	-4.09	Upgrade
EPS (Diluted)	-1.85	-4.00	-4.02	-2.77	-4.09	Upgrade
Free Cash Flow	9.33	-71.05	-120.41	-132.78	-89.3	Upgrade
Free Cash Flow Per Share	0.20	-1.74	-3.54	-4.38	-3.54	Upgrade
Gross Margin	75.77%	74.76%	83.94%	90.06%	-	Upgrade
Operating Margin	-26.00%	-58.57%	-170.28%	-906.12%	-	Upgrade
Profit Margin	-26.10%	-87.68%	-176.05%	-438.86%	-	Upgrade
Free Cash Flow Margin	2.77%	-38.12%	-156.26%	-693.81%	-	Upgrade
EBITDA	-63.98	-98.33	-127.98	-172.82	-103.99	Upgrade
EBITDA Margin	-18.99%	-52.76%	-166.08%	-	-	Upgrade
D&A For EBITDA	23.63	10.83	3.24	0.6	0.31	Upgrade
EBIT	-87.61	-109.15	-131.22	-173.41	-104.3	Upgrade
EBIT Margin	-26.00%	-58.57%	-170.28%	-	-	Upgrade
Revenue as Reported	336.89	186.37	77.06	19.14	-	Upgrade
Advertising Expenses	11.5	6.3	4	9.2	-	Upgrade

Updated Feb 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q